Vanguard Group Inc Guardant Health, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 12,052,551 shares of GH stock, worth $517 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,052,551
Previous 11,701,945
3.0%
Holding current value
$517 Million
Previous $268 Million
37.22%
% of portfolio
0.01%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding GH
# of Institutions
347Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Black Rock Inc. New York, NY11.2MShares$482 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$275 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$234 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$224 Million9.25% of portfolio
-
Wellington Management Group LLP Boston, MA4.85MShares$208 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.38B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...